DOI QR코드

DOI QR Code

Factors Associated with Attending the National Cancer Screening Program for Liver Cancer in Korea

  • Noh, Dai-Keun (National Cancer Control Institute, National Cancer Center) ;
  • Choi, Kui-Son (National Cancer Control Institute, National Cancer Center) ;
  • Jun, Jae-Kwan (National Cancer Control Institute, National Cancer Center) ;
  • Lee, Hoo-Yeon (Department of Social Medicine, College of Medicine, Dankook University) ;
  • Park, Eun-Cheol (Department of Preventive Medicine & Institute of Health Services Research, Yonsei University)
  • Published : 2012.02.29

Abstract

Background and Aims: The National Cancer Screening Program (NCSP) for liver cancer was initiated in 2003 in Korea. The objective of this study was to evaluate the participation rate of the program and to provide preliminary information on its results based on data collected by the NCSP in 2009. Methods: The target population of the NCSP for liver cancer in 2009 was comprised of 373,590 adults aged ${\geq}40$ years at high risk for liver cancer. Participation rates and positivity rates were assessed in this population. Multivariate logistic regression analysis was performed to determine the factors associated with participation in the NCSP for liver cancer. Results: The overall participation rate was 37.9% and 1,126 participants were positive at screening. The highest participation rates were observed in women, those in their 60s, National Health Insurance beneficiaries, and individuals positive for hepatitis B surface antigen. Positivity rates for men, those in their 70s, Medical Aid Program recipients and individuals with liver cirrhosis were the highest in the respective categories of gender, age, health insurance type, and risk factor for liver cancer. Conclusions: The participation rates of the NCSP for liver cancer are still low, despite the fact that the program targets a high-risk group much smaller than the general population. Efforts to facilitate participation and to reduce disparities in liver cancer screening among Korean men and women are needed. These results provide essential data for evidence-based strategies for liver cancer control in Korea.

Keywords

Liver cancer;screening;participation rate;positivity rate;factors;Korea

Acknowledgement

Supported by : National Cancer Center

References

  1. Ando E, Kuromatsu R, Tanaka M, et al. (2006). Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease. J Clin Gastroenterol, 40, 942-8. https://doi.org/10.1097/01.mcg.0000225675.14594.d6
  2. Benvegnu L, Fattovich G, Noventa F, et al. (1994). Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer, 74, 2442-8. https://doi.org/10.1002/1097-0142(19941101)74:9<2442::AID-CNCR2820740909>3.0.CO;2-#
  3. Boyle P, Levin B (Eds) (2008). World cancer report 2008, International Agency for Research on Cancer, Lyon.
  4. Chen TH, Chen CJ, Yen MF, et al. (2002). Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int J Cancer, 98, 257-61. https://doi.org/10.1002/ijc.10122
  5. Colombo M, Kuo G, Choo QL, et al. (1989). Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet, 2, 1006-8.
  6. Daniele B, Bencivenga A, Megna AS, et al. (2004). Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology, 127, S108- 12. https://doi.org/10.1053/j.gastro.2004.09.023
  7. Farmer MM, Bastani R, Kwan L, et al. (2008). Predictors of colorectal cancer screening from patients enrolled in a managed care health plan. Cancer, 112, 1230-8. https://doi.org/10.1002/cncr.23290
  8. Ferlay J, Shin H, Bray F, et al. (2010). GLOBALCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [internet]. Lyon, france: International Agency for Research on Cancer.
  9. Han KH, Park JW (2002). The usefulness and current status of the screening program for early diagnosis of hepatocellular carcinoma. J Korean Med Assoc, 45, 972-80. https://doi.org/10.5124/jkma.2002.45.8.972
  10. Jung KW, Park S, Kong HJ, et al. (2010). Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci, 25, 1113-21. https://doi.org/10.3346/jkms.2010.25.8.1113
  11. Kato Y, Nakata K, Omagari K, et al. (1994). Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses. Cancer, 74, 2234-8. https://doi.org/10.1002/1097-0142(19941015)74:8<2234::AID-CNCR2820740805>3.0.CO;2-6
  12. Kim CW, Lee SY, Moon OR (2008). Inequalities in cancer incidence and mortality across income groups and policy implications in South Korea. Public Health, 122, 229-36. https://doi.org/10.1016/j.puhe.2007.07.003
  13. Lee EH, Han MA, Lee HY, et al. (2010). Liver cancer screening in Korea: a report on the 2008 National Cancer Screening Programme. Asian Pac J Cancer Prev, 11, 1305-10.
  14. Meissner HI, Breen N, Klabunde CN, et al. (2006). Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev, 15, 389-94. https://doi.org/10.1158/1055-9965.EPI-05-0678
  15. Ministry of Health & Welfare, National Cancer Center (2010). Cancer facts & figures 2010 in the republic of Korea. In. Goyang, Korea: National Cancer Center.
  16. NHS Cancer Screening Programmes (2010a). NHS breast screening programme annual review 2010 [Internet]. In. Sheffield: NHS Cancer Screening Programmes.
  17. NHS Cancer Screening Programmes (2010b). NHS cervical screening programme annual review 2010 [Internet]. In. Sheffield: NHS Cancer Screening Programmes.
  18. Oka H, Tamori A, Kuroki T, et al. (1994). Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology, 19, 61-6. https://doi.org/10.1002/hep.1840190111
  19. Sangiovanni A, Del Ninno E, Fasani P, et al. (2004). Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology, 126, 1005-14. https://doi.org/10.1053/j.gastro.2003.12.049
  20. Won YJ, Sung J, Jung KW, et al. (2009). Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat, 41, 122-31. https://doi.org/10.4143/crt.2009.41.3.122
  21. Yoo KY (2008). Cancer control activities in the Republic of Korea. Jpn J Clin Oncol, 38, 327-33. https://doi.org/10.1093/jjco/hyn026
  22. Zhang BH, Yang BH, Tang ZY (2004). Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol, 130, 417-22.

Cited by

  1. Burden of Hepatocellular Carcinoma in Asia vol.13, pp.12, 2012, https://doi.org/10.7314/APJCP.2012.13.12.5955
  2. Cancer Screening in Korea, 2012: Results from the Korean National Cancer Screening Survey vol.14, pp.11, 2013, https://doi.org/10.7314/APJCP.2013.14.11.6459
  3. Factors Associated with Compliance with Recommendations for Liver Cancer Screening in Korea: A Nationwide Survey in Korea vol.8, pp.6, 2013, https://doi.org/10.1371/journal.pone.0068315
  4. Factors Associated with Alcohol Consumption in Hepatitis B Carriers: A Nationwide Study in the Republic of Korea vol.9, pp.11, 2014, https://doi.org/10.1371/journal.pone.0110144
  5. Need to Pay More Attention to Attendance at Follow-Up Consultation after Cancer Screening in Smokers and Drinkers vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.109
  6. Health Screening among HBV Carriers in the Korean National Health and Nutrition Examination Survey V (KNHANES V) vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3653
  7. Ten-Year Changes in the Hepatitis B Prevalence in the Birth Cohorts in Korea vol.94, pp.41, 2015, https://doi.org/10.1097/MD.0000000000001469